37
total announcements
TATVA.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 15 Oct 2026
Market Cap
₹4,539 Cr
P/E (TTM)
88.3
P/E (Forward)
47.5
EPS (TTM)
₹21.97
52W Low
₹1,044.10
52W High
₹2,008.70
Dividend Yield
0.11%
Beta
0.30
Price / Book
5.8
Debt / Equity
15.4
Revenue (TTM)
₹556 Cr
Gross Margin
56.57%
Operating Margin
13.01%
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an earnings call post announcement of financial results for the quarter and half year ended 30 September 2026. The call is hosted by ICICI Securities and is scheduled on Monday, 19 October 2026 at 5:00 p.m. (IST).
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming dematerialisation of securities and listing on stock exchanges.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 25, 2026, and informed the Exchange regarding voting results.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has held its 30th Annual General Meeting on September 25, 2026, through video conferencing. The meeting was attended by 56 members, and the company's financial highlights for the year ended March 31, 2026, were presented. The meeting approved the audited standalone and consolidated financial statements, and a dividend was declared for the financial year.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/con call.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an Analysts/Institutional Investor Meet/Con. Call, which will be held on 15 September 2026 with HSBC Securities and Capital Pvt. Ltd. in a virtual meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Credit Rating. CRISIL Ratings Limited has revised the ratings of the Company, upgrading the Long Term Rating to A-/Stable and the Short Term Rating to A2+.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about a copy of newspaper publication regarding the notice of the 30th Annual General Meeting of the Company scheduled to be held on September 25, 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has announced the record date for the purpose of dividend as 11-Sep-2026. The company's share transfer books will be closed from 12-Sep-2026 to 25-Sep-2026 for the 30th Annual General Meeting.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per Regulation 34(2)(f) of the SEBI Listing Regulations.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 25, 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the resignation of a Senior Management Personnel, Mr. Ajay Rawat, Assistant Vice President – Research and Development, effective from 13 November 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about Copy of Newspaper Publication regarding the 30th Annual General Meeting to be held on 25 September 2026 through Video Conferencing/OAVM.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange regarding the final dividend for FY 2025-26, with a dividend of Rs. 2.00 per equity share, and the process for claiming tax exemption or withholding tax on dividend payable to shareholders.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting on 12 August 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of Analyst(s)/Financial Institution(s)/Investor(s) meeting on 12 August 2026.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an analyst/institutional investor meet/conference call on August 6, 2026, to be held virtually.
Tatva Chintan Pharma Chem Limited
Tatva Chintan Pharma Chem Limited has informed the Exchange about the schedule of an Analyst(s)/Financial Institution(s)/Investor(s) meeting on August 6, 2026, to be held virtually. The meeting will discuss publicly available information, and no confidential or unpublished price-sensitive information will be shared.